Project deliverable Open Access

FAIRplus D1.01 First 3 data sets from Pilots selected and available

Gribbon, Philip; Gu, Wei; Sanz, Ferran; Ioannidis,Vassilios; Kohler, Manfred; Zaliani, Andrea; Henderson, David; Reilly, Dorothy; Rocca-Serra, Philippe


Citation Style Language JSON Export

{
  "publisher": "Zenodo", 
  "DOI": "10.5281/zenodo.3274230", 
  "language": "eng", 
  "title": "FAIRplus D1.01 First 3 data sets from Pilots selected and available", 
  "issued": {
    "date-parts": [
      [
        2019, 
        7, 
        9
      ]
    ]
  }, 
  "abstract": "<p>Candidate Pilot IMI projects (eTOX, ND4BB-TRANSLOCATION, ReSOLUTE, Aetionomy, OncoTrack and OPENPhacts) were initially identified based upon a long list highlighted in the DoA and through the FAIRplus partner network. Summaries of the activities and data sets available within these candidate Pilot IMI projects were collected via a survey tool, and further information was presented at the FAIRplus kick-off event by project owners. Following review, WP1 prioritized 4 IMI projects as Pilots, (eTOX, ND4BB-TRANSLOCATION, ReSOLUTE and OncoTrack). The prioritized Pilots were ratified by the General Assembly and formally selected. Each project was then assigned a key FAIRplus contact person, who worked with the data owners to identify, prioritise and release suitable data sets to the FAIRplus consortium, Squads and WP2 / 3 members. As of 30.06.2019, data sets have been released from eTOX, ND4BB-TRANSLOCATION and ReSOLUTE. OncoTrack is on course to release data in July 2019.</p>", 
  "author": [
    {
      "family": "Gribbon, Philip"
    }, 
    {
      "family": "Gu, Wei"
    }, 
    {
      "family": "Sanz, Ferran"
    }, 
    {
      "family": "Ioannidis,Vassilios"
    }, 
    {
      "family": "Kohler, Manfred"
    }, 
    {
      "family": "Zaliani, Andrea"
    }, 
    {
      "family": "Henderson, David"
    }, 
    {
      "family": "Reilly, Dorothy"
    }, 
    {
      "family": "Rocca-Serra, Philippe"
    }
  ], 
  "note": "This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 802750. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation and EFPIA companies.", 
  "type": "report", 
  "id": "3274230"
}
253
251
views
downloads
All versions This version
Views 253254
Downloads 251251
Data volume 147.2 MB147.2 MB
Unique views 235236
Unique downloads 232232

Share

Cite as